FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

233411000001102: Euglucon 2.5mg tablets (Aventis Pharma) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17180701000001110 Euglucon 2.5mg tablets (Aventis Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17180801000001118 Euglucon 2.5mg tablets (Aventis Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Euglucon 2.5mg tablets (Aventis Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Is a Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has excipient Lactose false Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has active ingredient Glibenclamide false Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has active ingredient Glyburide false Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has active ingredient Glibenclamide false Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Is a Euglucon true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has specific active ingredient Glibenclamide true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Euglucon 2.5mg tablets (Aventis Pharma) 28 tablet 2 x 14 tablets Is pack of False Euglucon 2.5mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier
Euglucon 2.5mg tablets (Aventis Pharma) 28 tablet 2 x 14 tablets Has AMP True Euglucon 2.5mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start